About Aspire

Aspire Pharma was established in 2009 from an entrepreneur’s vision to create a business which is agile to opportunity, unconstrained by market segment and whose products make a valuable difference to patients and payors.

Our approach

Innovation is at the heart of our global growth strategy, which we demonstrate by bringing products to existing and new markets with fresh ideas and ways of working, creating value and sustainability across our product portfolio. This includes improving patient access by focusing on niche generic medicines that provide solutions for complex and often rare medical challenges.

Innovation at Aspire

International reach

The internationalisation of Aspire is and has been a constant since our inception. We understand that access to knowledge around the world is fundamental to establishing both scientific and commercial collaborations that lead to solid and sustainable partnerships and growth.

View our journey

Sustainability

Our philosophy is to be better for the patient and the planet by focusing on sustainability across our operations and products. We are dedicated to meeting the UK’s National Health Service carbon reduction target to achieve a net-zero NHS by 2045.

Our social responsibility

Discover more

Careers

Our Journey

Innovation

Sustainability

“Through Aspire Pharma’s partnership principles, that are key to addressing complex healthcare challenges in the UK and EU markets we serve, we seek to establish transparent, honest relationships and maintain and grow our partnerships through shared knowledge and resources that accelerate progress.”

Richard Condon
Aspire Pharma Chief Executive Officer

Our markets

We have a deep knowledge of the UK healthcare system and are expanding into international markets around the world. Our competitive pricing and effective market access strategies, supported by exceptional customer service, are designed to provide quality and value to support the highest level of patient care.

Business Development